Literature DB >> 31680118

MicroRNA-200 family expression analysis in metastatic clear cell renal cell carcinoma patients.

Irina R Gilyazova1,2, Elizaveta A Klimentova1, Kirill V Bulygin3,4, Adel A Izmailov2, Marina A Bermisheva1, Elmira F Galimova2, Ruslan I Safiullin2, Shamil N Galimov2, Valentin N Pavlov2, Elsa K Khusnutdinova1,2.   

Abstract

The aim of this study is to analyse the of expression levels of microRNA-200 family members in patients with metastatic clear cell renal cell carcinoma (ccRCC). Analysis of microRNA expression was performed on 23 paired DNA samples extracted from kidney tumour tissue and the surrounding normal renal parenchyma. MicroRna-200c was found to have significantly lower expression (in kidney tumour tissue compared to normal renal parenchyma. No other microRna-200 family members showed statistically significant differences in expression levels between tumour and normal kidney tissue. Recent data suggest that the role of microRNA-200c in tumour pathogenesis is rather contradictory, and the underlying mechanisms by which microRNA-200c affects the carcinogenic potential of malignant cells remains unclear and requires further investigation at the molecular level.

Entities:  

Year:  2019        PMID: 31680118     DOI: 10.1038/s41417-019-0149-z

Source DB:  PubMed          Journal:  Cancer Gene Ther        ISSN: 0929-1903            Impact factor:   5.987


  4 in total

1.  MicroRNA Expression in Clear Cell Renal Cell Carcinoma Cell Lines and Tumor Biopsies: Potential Therapeutic Targets.

Authors:  Samuel Swearson; Aseel O Rataan; Steven Eliason; Brad A Amendt; Yousef Zakharia; Aliasger K Salem; Thai Ho; Youcef M Rustum
Journal:  Int J Mol Sci       Date:  2022-05-17       Impact factor: 6.208

Review 2.  Can miRNAs Be Considered as Diagnostic and Therapeutic Molecules in Ischemic Stroke Pathogenesis?-Current Status.

Authors:  Kirill V Bulygin; Narasimha M Beeraka; Aigul R Saitgareeva; Vladimir N Nikolenko; Ilgiz Gareev; Ozal Beylerli; Leila R Akhmadeeva; Liudmila M Mikhaleva; Luis Fernando Torres Solis; Arturo Solís Herrera; Marco F Avila-Rodriguez; Siva G Somasundaram; Cecil E Kirkland; Gjumrakch Aliev
Journal:  Int J Mol Sci       Date:  2020-09-14       Impact factor: 5.923

Review 3.  MicroRNA Signature in Renal Cell Carcinoma.

Authors:  Soudeh Ghafouri-Fard; Zeinab Shirvani-Farsani; Wojciech Branicki; Mohammad Taheri
Journal:  Front Oncol       Date:  2020-11-30       Impact factor: 6.244

4.  The Downregulation of Prognosis- and Immune Infiltration-Related Gene CYFIP2 Serves as a Novel Target in ccRCC.

Authors:  Junwei Tong; Xiangui Meng; Qingyang Lv; Hongwei Yuan; Weiquan Li; Wen Xiao; Xiaoping Zhang
Journal:  Int J Gen Med       Date:  2021-10-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.